Intellia Therapeutics Inc
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q3 and 2024-Q4. According to the most recent SEC 13F filing, 20 superinvestors own shares of Intellia Therapeutics Inc (NTLA), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Intellia Therapeutics Inc (NTLA), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Intellia Therapeutics Inc (NTLA) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Intellia Therapeutics Inc (NTLA) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
| Superinvestor | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
Jesper Bonnivier@Avanza Fonder Ab
| 0.02% | $420,518 36,065 shares@ 11.67 avg price | New Position |
Shawn Fischman@Fny Investment Advisers, Llc
| 0.16% | $306,000 26,260 shares@ 11.66 avg price | New Position |
Aryn Sands@Green Alpha Advisors, Llc
| 0.12% | $137,576 11,799 shares@ 11.66 avg price | New Position |
Brandon Yee@Versant Capital Management, Inc
| 0.01% | $1,749 150 shares@ 11.66 avg price | New Position |
Geoffrey A. Frazier@Global Financial Private Client, Llc
| 0.01% | $12 1 shares@ 12.0 avg price | New Position |